We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMF icon
3726
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.17B
$30K ﹤0.01%
76
+31
+69% +$13K
AIFU
3727
AIFU Inc
AIFU
$218M
$30K ﹤0.01%
4
-12
-75% -$97.7K
TIG
3728
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$30K ﹤0.01%
+1,998
New +$30.5K
ADTX
3729
DELISTED
ADITXT INC
ADTX
– –
0
– –
BABA icon
3730
Alibaba
BABA
$293B
$29K ﹤0.01%
97
-9,543
-99% -$2.51M
CIX icon
3731
Comp X International
CIX
$386M
$29K ﹤0.01%
1,909
+372
+24% +$5.17K
EFAV icon
3732
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
$29K ﹤0.01%
+422
New +$28.7K
EUO icon
3733
ProShares UltraShort Euro
EUO
$33.3M
$29K ﹤0.01%
1,183
-66
-5% -$1.63K
FINV
3734
FinVolution Group
FINV
$1.07B
$29K ﹤0.01%
+15,571
New +$30.8K
PRTH icon
3735
Priority Technology Holdings
PRTH
$458M
$29K ﹤0.01%
9,223
+7,674
+495% +$19K
SNDR icon
3736
Schneider National
SNDR
$6.27B
$29K ﹤0.01%
1,189
+708
+147% +$18.3K
TXG icon
3737
10x Genomics
TXG
$7.52B
$29K ﹤0.01%
235
-648
-73% -$68K
VNDA icon
3738
Vanda Pharmaceuticals
VNDA
$314M
$29K ﹤0.01%
3,031
-14,413
-83% -$154K
CMBT
3739
CMB.TECH NV
CMBT
$4.92B
$29K ﹤0.01%
+3,327
New +$31K
LGF.B
3740
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$29K ﹤0.01%
3,317
-13,736
-81% -$110K
FFNW
3741
DELISTED
First Financial Northwest, Inc
FFNW
$29K ﹤0.01%
3,187
+908
+40% +$8.43K
ADMS
3742
DELISTED
Adamas Pharmaceuticals
ADMS
$29K ﹤0.01%
7,126
+6,299
+762% +$24.4K
LEAF
3743
DELISTED
Leaf Group Ltd.
LEAF
$29K ﹤0.01%
5,772
-6,120
-51% -$28.9K
CHU
3744
DELISTED
China Unicom (HONG KONG) Limited
CHU
$29K ﹤0.01%
4,421
+1,490
+51% +$9.78K
ACET icon
3745
Adicet Bio
ACET
$77.3M
$28K ﹤0.01%
145
+111
+326% +$28.1K
CHGA
3746
Change Agents Corporation Common Stock
CHGA
$2.94M
$28K ﹤0.01%
150
+119
+384% +$27.1K
SRTA
3747
Strata Critical Medical Inc
SRTA
$533M
$28K ﹤0.01%
2,848
+2,671
+1,509% +$27K
CG icon
3748
Carlyle Group
CG
$17.2B
$28K ﹤0.01%
1,155
+164
+17% +$4.42K
EWI icon
3749
iShares MSCI Italy ETF
EWI
$1.08B
$28K ﹤0.01%
1,130
-666
-37% -$16.9K
GOSS icon
3750
Gossamer Bio
GOSS
$83.3M
$28K ﹤0.01%
2,232
-5,587
-71% -$74.1K
148 149
150
151 152

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.